LDL-cholesterol paradox in patients admitted with an acute coronary syndrome

被引：0
|
作者：
Timoteo, A. T. [1 ]
Ferreira, F. [1 ]
Miranda, F. [1 ]
Oliveira, J. A. [1 ]
Ferreira, M. L. [1 ]
Ferreira, R. C. [1 ]
机构：
[1] Hosp Santa Marta, Lisbon, Portugal
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] LDL-cholesterol goals and changes in C reactive protein in high coronary risk patients
    Costa, J. A.
    Rodilla, E.
    Perez-Lahiguera, F.
    Miralles, A.
    Gonzalez, C.
    Pascual, J. M.
    REVISTA CLINICA ESPANOLA, 2009, 209 (09): : 415 - 423
  • [42] Coronary event secondary prevention with statins irrespective of LDL-cholesterol
    Kerst, LL
    Mauro, VF
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (06) : 1060 - 1064
  • [43] Can cardiac rehabilitation improve LDL-cholesterol target attainment after acute coronary syndromes?
    Tokgozoglu, Lale
    Canpolat, Ugur
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (03) : 246 - 248
  • [44] The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis
    Momiyama, Yukihiko
    Ohmori, Reiko
    Fayad, Zahi A.
    Tanaka, Nobukiyo
    Kato, Ryuichi
    Taniguchi, Hiroaki
    Nagata, Masayoshi
    Ohsuzu, Fumitaka
    ATHEROSCLEROSIS, 2012, 222 (02) : 577 - 580
  • [45] LDL-Cholesterol is significantly lower in diabetic than in non-diabetic coronary patients
    Drexel, H
    Saely, C
    Hoefle, G
    Langer, P
    Vetter, Z
    Schuler, E
    Aczel, S
    DIABETES, 2001, 50 : A451 - A451
  • [46] New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes
    Sahebkar, Amirhossein
    Watts, Gerald F.
    CLINICAL THERAPEUTICS, 2013, 35 (08) : 1082 - 1098
  • [47] Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery Disease
    Bilato, Claudio
    Sesti, Giorgio
    Averna, Maurizio
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (05)
  • [48] ATORVASTATIN INCREASES PLASMA VITAMIN E/LDL-CHOLESTEROL AND COQ10/LDL-CHOLESTEROL RATIOS IN HYPERCHOLESTEROLAEMIC PATIENTS
    Cheng, W-L
    Kuo, C-L
    Liu, C-S
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [49] Quality control to improve LDL-cholesterol management in patients with acute coronary syndromes based on the ACS EuroPath IV project
    Schiele, Francois
    Catapano, Alberico L.
    De Caterina, Raffaele
    Laufs, Ulrich
    Jukema, J. Wouter
    Zaman, Azfar
    Sionis, Alessandro
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2024, 13 (01) : 46 - 54
  • [50] Improvement of coronary vasodilatation capacity after single LDL-cholesterol apheresis: Does the initial LDL-cholesterol level influence the therapeutic effect?
    Mellwig, KP
    Baller, D
    Burchert, W
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 443A - 444A
12345